Satisfaction, Pain and Function Outcomes of Breast Reduction Patients

Satisfaction, Pain and Function Outcomes of Breast Reduction Patients: A Retrospective Chart Review and Patient Follow up

To explore the indications and benefits of breast reduction. The investigators suspect all of the patients in this population suffer from neck/back pain and limitations in function. The investigators also want to review the patients in this group to determine if the amount of breast tissue removed or previous breast size affects outcomes for these patients. Patients will then be contacted for outcome data and satisfaction information. Ultimately, this information may lead to improvements in management and education of patients with macromastia.

Study Overview

• Status: Completed
• Conditions: Macromastia; Hypertrophy Breast

• Study Type: Observational
• Enrollment (Actual): 35

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 70 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Females age 21-70 with a diagnosis of hypertrophy of the breast who underwent surgical intervention

Description

Inclusion Criteria:

• Females
• Ages 21-71 years-old
• Hypertropy of the breast
• Macromastia
• post-surgical intervention for macromastia or hypertrophy of the breast

Exclusion Criteria:

• Males
• BMI>40
• Hypertrophy of the breast but without surgical intervention
• Macromastia but without surgical intervention

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
DASH questionnaire	Disabilities of the arm shoulder and hand, pain and function indicators	6 months
Breast Q questionnaire	quality of life questionnaire	6 months

Collaborators and Investigators

• Sponsor: Claytor Noone Plastic Surgery
• Investigators: Principal Investigator: Brannon Claytor, Claytor Noone Plastic Surgery

Study record dates

Study Major Dates

• Study Start (ACTUAL): October 1, 2016
• Primary Completion (ACTUAL): June 1, 2018
• Study Completion (ACTUAL): September 1, 2018

Study Registration Dates

• First Submitted: August 2, 2021
• First Submitted That Met QC Criteria: March 10, 2022
• First Posted (ACTUAL): March 21, 2022

Study Record Updates

• Last Update Posted (ACTUAL): March 21, 2022
• Last Update Submitted That Met QC Criteria: March 10, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Hypertrophy
• Other Study ID Numbers: R17-3683B

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No